Weekly Legislative Update: March 12, 2018

With the first committee deadline behind us and the 2018 Budget finally completed, the session focused on House and Senate Floor Action. The following describes the status of several pieces of legislation in which OSMA has interest. The next major legislative deadline is Thursday, March 15 whereby 2018 filed bills have to be passed out of the their “House of Origin”.

*E-Prescribing: OSMA understands the difficulty of accessibility, expense and time management associated with the implementation of such a structure. While deliberating, the Legislature should also consider an alternative method for compliance. (OSMA requested Sen. Yen, MD, to author an e-prescription measure. SB 1128: Title Stricken; Passed Senate Floor; to House for Committee assignment) OSMA Active in Negotiations

*Pill Limits: Restricting the availability of opioids is a recommendation from the Oklahoma Commission on Opioid Abuse. In order to assure a physician’s ability to address each case independently, any limitation should also allow an M.D. or D.O. to consider prescriptive authority on a case-by-case basis. OSMA is exploring the recommendations of the Centers for Disease Control and Prevention (CDC) limits for post-surgery; acute and chronic cases. (OSMA requested Sen. Sykes to author a Pill Limit bill. SB 1446: Title Stricken; Passed Senate Health & Human Services – to Senate Floor) OSMA Active in Negotiations

*Pain Management Clinic Regulation: Pain Management Clinics in Oklahoma should be licensed and regulated. Currently, they can be owned by non-physicians and provide limited oversight. Clinics should be owned by an individual or group of M.D.’s or D.O.’s and should designate a physician who is responsible for complying with clinic operations. (OSMA requested Sen. Yen, MD, to author a Pain Management Clinic Regulation bill. SB 1124: Title Stricken; Passed Senate Floor; to House for Committee assignment) OSMA Active in Negotiations

*Good Samaritan Law: Instances whereby a person is attempting to help another in the case of a suspected overdose should immune from prosecution based solely on an offense of drug possession or use. This is a Medical Student Advocacy Bill. (OSMA requested Sen Yen, MD, to author a Good Samaritan Law bill. SB 1367: Passed Senate Floor; to House for Committee assignment) OSMA STRONGLY SUPPORTS

Scope of Practice: OSMA STRONGLY OPPOSES efforts to undermine the authority and experience MD’s and DO’s provide to the medical profession. They should continue to deliver proper oversight of every patient’s well-being. In addition, in light of the opioid epidemic faced by our state and nation, the legislature should not be considering the expansion of prescriptive authority.

Payments for Oversight: SB 1127 (Yen/Cockroft) prohibits physicians from accepting monetary payments in exchange for nurse supervision oversight. (Failed on Senate Floor) OSMA SUPPORTS

Sunscreen for Students: SB 950 (Stanislawski) requires public schools to allow a student to possess and self-apply sunscreen which is regulated by the Food and Drug Administration without written authorization. This measure is another Medical Student Advocacy Bill. (Passed Senate Floor; to House for Committee assignment) OSMA SUPPORTS

*These measures reflect recommendations generated from Attorney General Mike Hunter’s Oklahoma Commission on Opioid Abuse on which Kevin Taubman, MD, OSMA President was an active participant.